These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2704374)

  • 1. Estimation of the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 by inhibition ELISA.
    van Dam GJ; Verheul AF; Zigterman GJ; de Reuver MJ; Snippe H
    Mol Immunol; 1989 Mar; 26(3):269-74. PubMed ID: 2704374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
    Sun Y; Hwang Yi; Nahm MH
    Infect Immun; 2001 Jan; 69(1):336-44. PubMed ID: 11119522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonionic block polymer surfactants enhance the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 in normal and Xid mice.
    Van Dam GJ; Verheul AF; Zigterman GJ; De Reuver MJ; Snippe H
    J Immunol; 1989 Nov; 143(9):3049-53. PubMed ID: 2809215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.
    Romero-Steiner S; Musher DM; Cetron MS; Pais LB; Groover JE; Fiore AE; Plikaytis BD; Carlone GM
    Clin Infect Dis; 1999 Aug; 29(2):281-8. PubMed ID: 10476727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.
    Levett PN; Sonnenberg K; Sidaway F; Shead S; Niedrig M; Steinhagen K; Horsman GB; Drebot MA
    J Clin Microbiol; 2005 Dec; 43(12):5873-5. PubMed ID: 16333069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies.
    Romero-Steiner S; Holder PF; Gomez de Leon P; Spear W; Hennessy TW; Carlone GM
    Clin Diagn Lab Immunol; 2005 Sep; 12(9):1029-35. PubMed ID: 16148167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of specific immunoglobulin G avidity enzyme linked immunosorbent assay (IgG avidity ELISA) in diagnosis of early and chronic Schistosomiasis mansoni.
    el Zayyat EA; Khalifa KE; el Gindy IM; Awad A; Azab ME
    J Egypt Soc Parasitol; 1998 Dec; 28(3):739-52. PubMed ID: 9914697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniques.
    Zigterman GJ; Verheul AF; Ernste EB; Rombouts RF; De Reuver MJ; Jansze M; Snippe H; Willers JM
    J Immunol Methods; 1988 Jan; 106(1):101-7. PubMed ID: 3339246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1. Evaluation of ELISA kit using outer membrane complex].
    Kishimoto T; Kubota Y; Matsushima T; Izutsu H; Matsumoto A; Soejima R; Morikawa T; Kawagoe K
    Kansenshogaku Zasshi; 1996 Aug; 70(8):821-9. PubMed ID: 8890550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate.
    Almanzar G; Ottensmeier B; Liese J; Prelog M
    J Immunol Methods; 2013 Jan; 387(1-2):36-42. PubMed ID: 23022630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avidity of IgG antibodies against meningococcal serogroup a polysaccharide and correlations with bactericidal activity in sera from meningitis patients and controls from Ethiopia.
    Medhane M; Tunheim G; Naess LM; Mihret W; Bedru A; Norheim G; Petros B; Aseffa A; Rosenqvist E
    Scand J Immunol; 2014 Apr; 79(4):267-75. PubMed ID: 24383864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays.
    Harris SL; Tsao H; Ashton L; Goldblatt D; Fernsten P
    Clin Vaccine Immunol; 2007 Apr; 14(4):397-403. PubMed ID: 17287312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designation of an in-house ELISA for detection of VZV IgG and determination of antibody avidity by use of diethylamine.
    Fard AH; Pam JV
    Pak J Biol Sci; 2007 Oct; 10(19):3306-13. PubMed ID: 19090145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine.
    Koskela M; Leinonen M
    J Clin Pathol; 1981 Jan; 34(1):93-8. PubMed ID: 7007449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of cross-protection against invasive pneumonia caused by heterologous strains following murine Streptococcus pneumoniae nasopharyngeal colonisation despite whole cell ELISAs showing significant cross-reactive IgG.
    Cohen JM; Wilson R; Shah P; Baxendale HE; Brown JS
    Vaccine; 2013 May; 31(19):2328-32. PubMed ID: 23523406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring.
    Villalta D; Romelli PB; Savina C; Bizzaro N; Tozzoli R; Tonutti E; Ghirardello A; Doria A
    Lupus; 2003; 12(1):31-6. PubMed ID: 12587824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of avidity of IgG against protein antigens from Streptococcus pneumoniae: assay development and preliminary application in clinical settings.
    Andrade DC; Borges IC; Ekström N; Jartti T; Puhakka T; Barral A; Kayhty H; Ruuskanen O; Nascimento-Carvalho CM
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):77-89. PubMed ID: 29027028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avidity of anti-Yersinia antibodies in yersiniosis patients with and without Yersinia-triggered reactive arthritis.
    Lahesmaa-Rantala R; Lehtonen OP; Granfors K; Toivanen A
    Arthritis Rheum; 1987 Oct; 30(10):1176-81. PubMed ID: 3675663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
    Prince HE; Leber AL
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.